Glaukos Corporation (GKOS) Live Stock Price, Forecast & News

Glaukos Corporation
GKOS
(NYSE)
Open
139.40
+0.96 (+0.69%)
in:usd•As of: Nov 18, 2024 10:38 UTC -5
Open
138.37
High
139.49
Low
138.22

Stats

Prev. Close

138.44

Open

138.37

Day's Range

138.22 - 139.49

52 Week Range

59.22 - 145.84

YTD Change

75.37%

1 Year Change

117.61%

Market Cap

7.69B

P/E Ratio

N/A

Volume

1,937.00

Beta

1.02

Sector

Health Technology

Industry

Medical Specialties

Economic CalendarAll Events

Time zone: GMT

Friday, November 15th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
15:00	USD	Business Inventories MoMSep	Medium	0.1%	0.2%	0.3%

Saturday, November 16th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
16:55	USD	Fed Collins Speech	Medium

Monday, November 18th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
15:00	USD	NAHB Housing Market IndexNov	Medium	46	44	43
15:00	USD	Fed Goolsbee Speech	Medium
21:00	USD	Net Long-term TIC FlowsSep	Medium		$114.3B	$111.4B

Tuesday, November 19th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:30	USD	Housing Starts MoMOct	Medium		-0.2%	-0.5%
13:30	USD	Housing StartsOct	Medium		1.34M	1.354M

Latest News

Zacks Investment ResearchNov 5, 2024

Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

GKOS+0.69%

BenzingaNov 5, 2024

Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds

GKOS+0.69%

Zacks Investment ResearchNov 5, 2024

GKOS Stock Declines Despite Q3 Earnings & Revenues Beat Estimates

GKOS+0.69%

Seeking AlphaNov 5, 2024

Glaukos Corporation (GKOS) Q3 2024 Earnings Call Transcript

GKOS+0.69%

Zacks Investment ResearchNov 4, 2024

Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

GKOS+0.69%

Zacks Investment ResearchOct 28, 2024

Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

GKOS+0.69%

Read All

Data Vendor: Xignite Logo

Stocks

Glaukos Corporation

Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds

GKOS Stock Declines Despite Q3 Earnings & Revenues Beat Estimates

Glaukos Corporation (GKOS) Q3 2024 Earnings Call Transcript

Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Trade With A Regulated Broker